SMARTVIEWS: Off-label but under debate
Off-label use of medicines has always been a vexed issue. In theory, treatments should only be used as indicated, where their safety and efficacy has been proven. Indeed, several pharma companies have received large fines for suggesting otherwise in
by Ana Nicholls, Economist Intelligence Unit
www.pharmatimes.com/news/smartviews_off-label_but_under_debate_971338